-
1
-
-
30144443996
-
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001
-
DOI 10.1182/blood-2005-06-2508
-
LM Morton, SS Wang, SS Devesa, P Hartge, DD Weisenburger, MS Linet Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood 107 2006 265 276 (Pubitemid 43053551)
-
(2006)
Blood
, vol.107
, Issue.1
, pp. 265-276
-
-
Morton, L.M.1
Wang, S.S.2
Devesa, S.S.3
Hartge, P.4
Weisenburger, D.D.5
Linet, M.S.6
-
2
-
-
0037165261
-
Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma
-
DOI 10.1056/NEJMoa011795
-
B Coiffier, E Lepage, J Briere et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 2002 235 242 (Pubitemid 34438862)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.4
, pp. 235-242
-
-
Coiffier, B.1
Lepage, E.2
Briere, J.3
Herbrecht, R.4
Tilly, H.5
Bouabdallah, R.6
Morel, P.7
Van Den Neste, E.8
Salles, G.9
Gaulard, P.10
Reyes, F.11
Lederlin, P.12
Gisselbrecht, C.13
-
3
-
-
77957200763
-
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe d'Etudes des Lymphomes de l'Adulte
-
B Coiffier, C Thieblemont, E Van Den Neste et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte Blood 116 2010 2040 2045
-
(2010)
Blood
, vol.116
, pp. 2040-2045
-
-
Coiffier, B.1
Thieblemont, C.2
Van Den Neste, E.3
-
4
-
-
33745982067
-
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
-
DOI 10.1200/JCO.2005.05.1003
-
TM Habermann, EA Weller, VA Morrison et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma J Clin Oncol 24 2006 3121 3127 (Pubitemid 46638950)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.19
, pp. 3121-3127
-
-
Habermann, T.M.1
Weller, E.A.2
Morrison, V.A.3
Gascoyne, R.D.4
Cassileth, P.A.5
Cohn, J.B.6
Dakhil, S.R.7
Woda, B.8
Fisher, R.I.9
Peterson, B.A.10
Horning, S.J.11
-
5
-
-
33646004738
-
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group
-
M Pfreundschuh, L Trumper, A Osterborg et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 2006 379 391
-
(2006)
Lancet Oncol
, vol.7
, pp. 379-391
-
-
Pfreundschuh, M.1
Trumper, L.2
Osterborg, A.3
-
6
-
-
38549147027
-
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: A randomised controlled trial (RICOVER-60)
-
M Pfreundschuh, J Schubert, M Ziepert et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Lancet Oncol 9 2008 105 116
-
(2008)
Lancet Oncol
, vol.9
, pp. 105-116
-
-
Pfreundschuh, M.1
Schubert, J.2
Ziepert, M.3
-
7
-
-
77957965500
-
Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era
-
C Gisselbrecht, B Glass, N Mounier et al. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era J Clin Oncol 28 2010 4184 4190
-
(2010)
J Clin Oncol
, vol.28
, pp. 4184-4190
-
-
Gisselbrecht, C.1
Glass, B.2
Mounier, N.3
-
8
-
-
20144369743
-
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma
-
DOI 10.1056/NEJMoa042040
-
F Reyes, E Lepage, G Ganem et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma N Engl J Med 352 2005 1197 1205 (Pubitemid 40397261)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.12
, pp. 1197-1205
-
-
Reyes, F.1
Lepage, E.2
Ganem, G.3
Molina, T.J.4
Brice, P.5
Coiffier, B.6
Morel, P.7
Ferme, C.8
Bosly, A.9
Lederlin, P.10
Laurent, G.11
Tilly, H.12
-
9
-
-
10744224285
-
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
-
DOI 10.1182/blood-2003-02-0542
-
H Tilly, E Lepage, B Coiffier et al. Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma Blood 102 2003 4284 4289 (Pubitemid 37494085)
-
(2003)
Blood
, vol.102
, Issue.13
, pp. 4284-4289
-
-
Tilly, H.1
Lepage, E.2
Coiffier, B.3
Blanc, M.4
Herbrecht, R.5
Bosly, A.6
Attal, M.7
Fillet, G.8
Guettier, C.9
Molina, T.J.10
Gisselbrecht, C.11
Reyes, F.12
-
10
-
-
0027444652
-
A predictive model for aggressive non-Hodgkin's lymphoma
-
The International Non-Hodgkin's Lymphoma Prognostic Factors Project
-
The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 1993 987 994
-
(1993)
N Engl J Med
, vol.329
, pp. 987-994
-
-
-
11
-
-
3042813710
-
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: Results of the NHL-B1 trial of the DSHNHL
-
DOI 10.1182/blood-2003-06-2094
-
M Pfreundschuh, L Trumper, M Kloess et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL Blood 104 2004 626 633 (Pubitemid 38970553)
-
(2004)
Blood
, vol.104
, Issue.3
, pp. 626-633
-
-
Pfreundschuh, M.1
Trumper, L.2
Kloess, M.3
Schmits, R.4
Feller, A.C.5
Rudolph, C.6
Reiser, M.7
Hossfeld, D.K.8
Metzner, B.9
Hasenclever, D.10
Schmitz, N.11
Glass, B.12
Rube, C.13
Loeffler, M.14
-
14
-
-
0042449063
-
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
-
BD Cheson, SJ Horning, B Coiffier et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group J Clin Oncol 17 1999 1244 1250
-
(1999)
J Clin Oncol
, vol.17
, pp. 1244-1250
-
-
Cheson, B.D.1
Horning, S.J.2
Coiffier, B.3
-
15
-
-
33646783722
-
-
National Cancer Institute (accessed Oct 11, 2011)
-
National Cancer Institute Common terminology criteria for adverse events v3.0 http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ ctcaev3.pdf (accessed Oct 11, 2011).
-
Common Terminology Criteria for Adverse Events v3.0
-
-
-
16
-
-
34447626101
-
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: A multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
-
DOI 10.1038/sj.leu.2404781, PII 2404781
-
C Tarella, M Zanni, M Di Nicola et al. Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) Leukemia 21 2007 1802 1811 (Pubitemid 47086769)
-
(2007)
Leukemia
, vol.21
, Issue.8
, pp. 1802-1811
-
-
Tarella, C.1
Zanni, M.2
Di Nicola, M.3
Patti, C.4
Calvi, R.5
Pescarollo, A.6
Zoli, V.7
Fornari, A.8
Novero, D.9
Cabras, A.10
Stella, M.11
Comino, A.12
Remotti, D.13
Ponzoni, M.14
Caracciolo, D.15
Ladetto, M.16
Magni, M.17
Devizzi, L.18
Rosato, R.19
Boccadoro, M.20
Bregni, M.21
Corradini, P.22
Gallamini, A.23
Majolino, I.24
Mirto, S.25
Gianni, A.M.26
more..
-
17
-
-
70349128174
-
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: A phase II multicenter study
-
U Vitolo, A Chiappella, E Angelucci et al. Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study Haematologica 94 2009 1250 1258
-
(2009)
Haematologica
, vol.94
, pp. 1250-1258
-
-
Vitolo, U.1
Chiappella, A.2
Angelucci, E.3
-
18
-
-
77958453257
-
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma
-
B Glass, M Ziepert, M Reiser et al. High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma Ann Oncol 21 2010 2255 2261
-
(2010)
Ann Oncol
, vol.21
, pp. 2255-2261
-
-
Glass, B.1
Ziepert, M.2
Reiser, M.3
-
19
-
-
45749152667
-
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers
-
WH Wilson, K Dunleavy, S Pittaluga et al. Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers J Clin Oncol 26 2008 2717 2724
-
(2008)
J Clin Oncol
, vol.26
, pp. 2717-2724
-
-
Wilson, W.H.1
Dunleavy, K.2
Pittaluga, S.3
-
20
-
-
0022571464
-
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)
-
B Coiffier, PA Bryon, F Berger et al. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80) J Clin Oncol 4 1986 147 153 (Pubitemid 16161028)
-
(1986)
Journal of Clinical Oncology
, vol.4
, Issue.2
, pp. 147-153
-
-
Coiffier, B.1
Bryon, P.A.2
Berger, F.3
-
21
-
-
0024379544
-
LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma
-
B Coiffier, C Gisselbrecht, R Herbrecht, H Tilly, A Bosly, N Brousse LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma J Clin Oncol 7 1989 1018 1026 (Pubitemid 19196524)
-
(1989)
Journal of Clinical Oncology
, vol.7
, Issue.8
, pp. 1018-1026
-
-
Coiffier, B.1
Gisselbrecht, C.2
Herbrecht, R.3
Tilly, H.4
Bosly, A.5
Brousse, N.6
-
22
-
-
40149103276
-
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2
-
DOI 10.1093/annonc/mdm520
-
P Morel, P Gaulard, C Gisselbrecht et al. Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2 Ann Oncol 19 2008 560 565 (Pubitemid 351325679)
-
(2008)
Annals of Oncology
, vol.19
, Issue.3
, pp. 560-565
-
-
Morel, P.1
Gaulard, P.2
Gisselbrecht, C.3
Ferme, C.4
Salles, G.5
Tilly, H.6
Briere, J.7
Copin, M.C.8
Lederlin, P.9
Hermine, O.10
Theate, I.11
Haioun, C.12
Mounier, N.13
-
23
-
-
79960116662
-
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
-
RO Casasnovas, M Meignan, A Berriolo-Riedinger et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma Blood 118 2011 37 43
-
(2011)
Blood
, vol.118
, pp. 37-43
-
-
Casasnovas, R.O.1
Meignan, M.2
Berriolo-Riedinger, A.3
-
24
-
-
77957331593
-
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
-
JS Abramson, M Hellmann, JA Barnes et al. Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma Cancer 116 2010 4283 4290
-
(2010)
Cancer
, vol.116
, pp. 4283-4290
-
-
Abramson, J.S.1
Hellmann, M.2
Barnes, J.A.3
-
25
-
-
0036064595
-
Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: A GELA study
-
DOI 10.1046/j.1365-2141.2002.03565.x
-
C Dumontet, N Mounier, JN Munck et al. Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: a GELA study Br J Haematol 118 2002 210 217 (Pubitemid 34779539)
-
(2002)
British Journal of Haematology
, vol.118
, Issue.1
, pp. 210-217
-
-
Dumontet, C.1
Mounier, N.2
Munck, J.N.3
Bosly, A.4
Morschauser, F.5
Simon, D.6
Marit, G.7
Casasnovas, O.8
Reman, O.9
Molina, T.10
Reyes, F.11
Coiffier, B.12
-
26
-
-
10744231424
-
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA cohort study on 2837 patients
-
DOI 10.1182/blood-2003-04-1124
-
M André, N Mounier, X Leleu et al. Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients Blood 103 2004 1222 1228 (Pubitemid 38168631)
-
(2004)
Blood
, vol.103
, Issue.4
, pp. 1222-1228
-
-
Andre, M.1
Mounier, N.2
Leleu, X.3
Sonet, A.4
Brice, P.5
Henry-Amar, M.6
Tilly, H.7
Coiffier, B.8
Bosly, A.9
Morel, P.10
Haioun, C.11
Gaulard, P.12
Reyes, F.13
Gisselbrecht, C.14
-
27
-
-
77958501473
-
DNA damage-mediated induction of a chemoresistant niche
-
LA Gilbert, MT Hemann DNA damage-mediated induction of a chemoresistant niche Cell 143 2010 355 366
-
(2010)
Cell
, vol.143
, pp. 355-366
-
-
Gilbert, L.A.1
Hemann, M.T.2
-
28
-
-
77950332103
-
Rituximab: Mechanism of action
-
GJ Weiner Rituximab: mechanism of action Semin Hematol 47 2010 115 123
-
(2010)
Semin Hematol
, vol.47
, pp. 115-123
-
-
Weiner, G.J.1
-
29
-
-
77951010885
-
Aggressive lymphomas
-
G Lenz, LM Staudt Aggressive lymphomas N Engl J Med 362 2010 1417 1429
-
(2010)
N Engl J Med
, vol.362
, pp. 1417-1429
-
-
Lenz, G.1
Staudt, L.M.2
|